Systematic Review With Meta-analysis: Safety and Effectiveness of Combining Biologics and Small Molecules in Inflammatory Bowel Disease
18 auth.
Q. Alayo,
M. Fenster,
Osama Altayar,
Kerri Glassner,
Ernesto M Llano,
Kindra Clark‐Snustad,
A. Patel,
L. Kwapisz,
A. Yarur,
B. Cohen,
...
M. Ciorba,
Deborah Thomas,
S. Lee,
E. Loftus,
David I. Fudman,
B. Abraham,
J. Colombel,
P. Deepak
|
5 |
2022 |
5
2022
|
The Risk of SARS-CoV-2 in Immunosuppressed IBD Patients
P. Higgins,
S. Ng,
S. Danese,
Krishna Rao
|
5 |
2020 |
5
2020
|
Efficacy and Safety of Advanced Therapies for Moderately to Severely Active Ulcerative Colitis at Induction and Maintenance: An Indirect Treatment Comparison Using Bayesian Network Meta-analysis
12 auth.
R. Panaccione,
Eric B Collins,
G. Melmed,
S. Vermeire,
S. Danese,
P. Higgins,
...
C. Kwon,
Wen Zhou,
D. Ilo,
Dolly Sharma,
Y. Sanchez Gonzalez,
Si-Tien Wang
|
5 |
2023 |
5
2023
|
Fecal MicroRNAs Show Promise as Noninvasive Crohn’s Disease Biomarkers
21 auth.
Christian T. Wohnhaas,
R. Schmid,
Marcel Rolser,
Eric Kaaru,
D. Langgartner,
Kathrin Rieber,
B. Strobel,
Claudia Eisele,
F. Wiech,
Ines Jakob,
...
F. Gantner,
I. Herichova,
R. Vinisko,
W. Böcher,
S. Visvanathan,
Fei Shen,
M. Panzenbeck,
E. Raymond,
S. Reber,
D. Delić,
P. Baum
|
4 |
2020 |
4
2020
|
Full, Partial, and Modified Permutations of the Mayo Score: Characterizing Clinical and Patient-Reported Outcomes in Ulcerative Colitis Patients
8 auth.
A. Naegeli,
T. Hunter,
Yan Dong,
B. Hoskin,
C. Middleton-Dalby,
J. Hetherington,
...
D. Stefani-Hunyady,
J. Canavan
|
4 |
2021 |
4
2021
|
Elevated Pretreatment Plasma Oncostatin M Is Associated With Poor Biochemical Response to Infliximab
P. Minar,
Christina N. Lehn,
Y. Tsai,
K. Jackson,
M. Rosen,
L. Denson
|
4 |
2019 |
4
2019
|
Trends and Characteristics of Clinical Trials Participation for Inflammatory Bowel Disease in the United States: A Report From IBD Partners
Cole Johnson,
E. Barnes,
Xian Zhang,
M. Long
|
4 |
2020 |
4
2020
|
Real-World Effectiveness and Safety of Ustekinumab for Ulcerative Colitis From 2 Tertiary IBD Centers in the United States
11 auth.
Simon J. Hong,
N. Krugliak Cleveland,
Shintaro Akiyama,
Samantha Zullow,
Yangtian Yi,
S. Shaffer,
...
L. Malter,
J. Axelrad,
Shannon Chang,
D. Hudesman,
D. Rubin
|
4 |
2021 |
4
2021
|
Comparison of Real-World Treatment Outcomes With Vedolizumab Versus Infliximab in Biologic-Naive Patients With Inflammatory Bowel Disease
Haridarshan Patel,
D. Latremouille-Viau,
R. Burne,
Sherry Shi,
S. Adsul
|
4 |
2019 |
4
2019
|
Medicinal Cannabis for Inflammatory Bowel Disease: A Survey of Perspectives, Experiences, and Current Use in Australian Patients
8 auth.
M. Benson,
Sarah V. Abelev,
S. Connor,
C. Corte,
Lewis J Martin,
Lucy K Gold,
...
Anastasia S. Suraev,
I. McGregor
|
4 |
2020 |
4
2020
|
